IRD vs MKTX · rev $11.0M vs P/E 13, rev $817.1M
Opus Genetics, Inc. (IRD) versus MarketAxess Holdings Inc (MKTX) — a side-by-side from cached financials, not a winner call.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
MarketAxess Holdings Inc (MKTX) is a capital markets company listed on US.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
Latest reported MKTX revenue for 2024-12-31 was $817.1M. Net income was $274.2M. Revenue was up 8.6% from 2023-12-31 to 2024-12-31. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
IRD currently screens at market cap $35.7M. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
Not investment advice. Open the IRD and MKTX stock pages for the full models.
Not investment advice.